adult-onset diabet afflict estim 10 million
american mani case control without drug
diet exercis third requir insulin
inject might benefit insulinotropin drug
discov 1986 massachusett general hospit
licens california biotechnolog inc. mountain
view calif. develop collabor
pfizer inc. new york insulinotropin potenti
annual sale $ 200 million $ 400 million estim david
k. stone analyst cowen co
drug wo use treat diabet
sever juvenile-onset type diabet
pancreas produc insulin insulinotropin ca
stimul releas may eventu displac
signific portion injectable-insulin sale estim
$ 500 million annual eli lilli co.
domin seller insulin also sold novo
industri denmark
insulin induc liver muscl cell absorb glucos
blood keep blood-sugar level control
rise meal diabet inject insulin
howev level vari concert level
glucos caus blood glucos level fall
much induc danger hypoglycem shock moreov
scientist believ diabet wide swing glucos level
also caus mani diseas complic includ
blind clog arteri lead heart diseas
kidney damag
anim studi shown insulinotropin
insulin-releas effect fall conjunct drop
blood sugar indic control glucos
natur pattern insulin inject said joel f
haben lead research insulinotropin
massachusett general hospit ad unlik inject
insulin insulinotropin expos muscl cell
frequent dose insulin anoth sourc side
effect includ breakdown tissu inject
site
latest studi nine peopl type ii diabet
two non-diabet volunt given continu intraven
dose insulinotropin fast eat
boston hospit infus insulin level
rose factor three hope fell blood
glucos level result studi report
februari issu journal diabet care
problem hypoglycemia even whop
dose insulinotropin said dr. haben caution
howev clinic test drug expect
continu least two year becom wide
avail diabet
ken luskey california biotechnolog director
diabet obes research ad pfizer
separ conduct phase ii clinic trial drug
aim establish efficaci result
test disclos
